Imetelstat for treating relapsed or refractory transfusion-dependent myelodysplastic syndromes [ID3922]
In development
Reference number: GID-TA10800
Expected publication date: TBC
Please note that following on from advice received from the company the timelines for this appraisal are to be confirmed. The appraisal will be scheduled to align with latest regulatory expectations and an update on the timelines will be provided when further information is available.